Innovative Treatments and Hopeful Advances in IgA Nephropathy Management
Bisphosphonates and Cinacalcet: A Hopeful Solution for Post-Transplant Challenges
South Korea Approves Nefecon for Primary IgA Nephropathy Treatment
Full Approval for New IgAN Treatments
Critical advancements in IgAN treatments and understanding of risk factors.
Breakthroughs, management options, and the impact of kidney disease on reproductive health
Biogen's Phase 2 Success, Oxford Classification for Pediatric Outcomes, and Nefecon's Long-term Management Potential.
Significant funding milestones for IgA nephropathy gene therapy and, innovative predictive tools for paediatric care
